Enhanced MAPK1 Function Causes a Neurodevelopmental Disorder within the RASopathy Clinical Spectrum
- 3 September 2020
- journal article
- research article
- Published by Elsevier BV in American Journal of Human Genetics
- Vol. 107 (3), 499-513
- https://doi.org/10.1016/j.ajhg.2020.06.018
Abstract
No abstract availableFunding Information
- Associazione Italiana per la Ricerca sul Cancro
This publication has 64 references indexed in Scilit:
- The RASopathiesAnnual Review of Genomics and Human Genetics, 2013
- A Smoothed Backbone-Dependent Rotamer Library for Proteins Derived from Adaptive Kernel Density Estimates and RegressionsStructure, 2011
- Disorders of dysregulated signal traffic through the RAS‐MAPK pathway: phenotypic spectrum and molecular mechanismsAnnals of the New York Academy of Sciences, 2010
- Diverse driving forces underlie the invariant occurrence of the T42A, E139D, I282V and T468M SHP2 amino acid substitutions causing Noonan and LEOPARD syndromesHuman Molecular Genetics, 2008
- Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndromeNature Genetics, 2006
- Germline gain-of-function mutations in SOS1 cause Noonan syndromeNature Genetics, 2006
- The gatekeeper residue controls autoactivation of ERK2 via a pathway of intramolecular connectivityProceedings of the National Academy of Sciences of the United States of America, 2006
- Functions of the MAPK family in vertebrate‐developmentFEBS Letters, 2006
- UCSF Chimera?A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004
- A Bipartite Mechanism for ERK2 Recognition by Its Cognate Regulators and SubstratesOnline Journal of Public Health Informatics, 2003